Please assess the completion status of the following clinical trial:

Trial Title: Pregabalin Treatment for Trigger Points

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who diagnosed fibromyalgia syndrome,~* Patients who were also diagnosed as cervical myofascial pain syndrome based on the upper trapezius muscle~Exclusion Criteria:~* Patients who had received dry needling or local anesthetic injection to trigger point in the dominant upper trapezius muscle within 3 months of the start of the study.~* renal insufficiency,~* impaired liver function,~* malignancy,~* pregnancy~* infections,~* history of drug or alcohol abuse

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): Patients received pregabalin (target dose 300 mg/day) and exercise therapy (stretching exercises for the trapezius muscle). Patients were instructed to perform 10 repetitions three times a day., 3 months
- Group 2 (Type: NO_INTERVENTION): Patients received exercise therapy alone (stretching exercises for the trapezius muscle). Patients were instructed to perform 10 repetitions three times a day., 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).